Boston Scientific Announces Results for Fourth Quarter and Full Year 2017

Go back to Boston Scientific Announces Results for Fourth Quarter and Full Year 2017

Boston Scientific (BSX) PT Raised to $35 at Needham & Company

February 1, 2018 3:28 PM EST

Needham & Company raised its price target on Boston Scientific (NYSE: BSX) to $35.00 (from $32.00) while maintaining a Strong Buy rating.

Analyst Mike Matson commented, "BSX's 4Q17 revenue was consistent with its 1/9/18 preannouncement while its EPS met consensus. Management provided initial 2018 revenue guidance... More

Boston Scientific (BSX) PT Raised to $31 at Stifel

February 1, 2018 2:46 PM EST

Stifel raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $30.00) while maintaining a Buy rating.

... More

Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI

February 1, 2018 12:45 PM EST

Evercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $27.00) while maintaining a In Line rating.

... More

Boston Scientific (BSX) Reports In-Line Q4 EPS

February 1, 2018 6:32 AM EST

Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.38 billion.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.

... More